Center-Authored Papers

Filters: Author is Wang, Hong  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zhang Q, Menon R, Deutsch EW, Pitteri SJ, Faca VM, Wang H, Newcomb LF, DePinho RA, Bardeesy N, Dinulescu D et al..  2008.  A mouse plasma peptide atlas as a resource for disease proteomics.. Genome biology. 9(6):R93. Abstract
Zeng Z, Hincapie M, Pitteri SJ, Hanash SM, Schalkwijk J, Hogan JM, Wang H, Hancock WS.  2011.  A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome.. Analytical chemistry. 83(12):4845-54. Abstract
W
Wang H, Hanash SM.  2011.  Intact-protein analysis system for discovery of serum-based disease biomarkers.. Methods in molecular biology (Clifton, N.J.). 728:69-85. Abstract
Wang H, Hanash SM.  2008.  Increased throughput and reduced carryover of mass spectrometry-based proteomics using a high-efficiency nonsplit nanoflow parallel dual-column capillary HPLC system.. Journal of proteome research. 7(7):2743-55. Abstract
Wang H, Wong C-H, Chin A, Kennedy J, Zhang Q, Hanash SM.  2009.  Quantitative serum proteomics using dual stable isotope coding and nano LC-MS/MSMS.. Journal of proteome research. 8(12):5412-22. Abstract
Wang H, Wong C-H, Chin A, Taguchi A, Taylor A, Hanash SM, Sekiya S, Takahashi H, Murase M, Kajihara S et al..  2011.  Integrated mass spectrometry-based analysis of plasma glycoproteins and their glycan modifications.. Nature protocols. 6(3):253-69. Abstract
Wang H, Hanash SM.  2009.  Electrospray mass spectrometry for quantitative plasma proteome analysis.. Methods in molecular biology (Clifton, N.J.). 564:227-42. Abstract
V
Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH, Zhang Q, Wong C-H, Wang H, Chin A et al..  2013.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.. The New England journal of medicine. 369(6):529-39. Abstract
T
Taguchi A, Rho J-H, Yan Q, Zhang Y, Zhao Y, Xu H, Tripathi SC, Wang H, Brenner D, Kucherlapati M et al..  2015.  MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas.. Cancer prevention research (Philadelphia, Pa.). Abstract
S
Sorensen MD, Chi T, Shara NM, Wang H, Hsi RS, Orchard T, Kahn AJ, Jackson RD, Miller J, Reiner AP et al..  2014.  Activity, Energy Intake, Obesity, and the Risk of Incident Kidney Stones in Postmenopausal Women: A Report from the Women's Health Initiative.. Journal of the American Society of Nephrology : JASN. 25(2):362-9. Abstract
Schliekelman MJ, Taguchi A, Zhu J, Dai X, Rodriguez J, Celiktas M, Zhang Q, Chin A, Wong C-H, Wang H et al..  2015.  Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival.. Cancer research. 75(9):1789-800. Abstract
Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong C-H, Wang H, Ungewiss C, Ahn Y-H et al..  2011.  Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial-Mesenchymal Transition in Cancer.. Cancer research. 71(24):7670-7682. Abstract
Q
Qiu J, Choi G, Li L, Wang H, Pitteri SJ, Pereira-Faca SR, Krasnoselsky AL, Randolph TW, Omenn GS, Edelstein C et al..  2008.  Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(31):5060-6. Abstract
P
Pitteri SJ, Kelly-Spratt KS, Gurley KE, Kennedy J, Busald Buson T, Chin A, Wang H, Zhang Q, Wong C-H, Chodosh LA et al..  2011.  Tumor Microenvironment-Derived Proteins Dominate the Plasma Proteome Response during Breast Cancer Induction and Progression.. Cancer research. 71(15):5090-100. Abstract
Pitteri SJ, JeBailey L, Faça VM, Thorpe JD, Silva MA, Ireton RC, Horton MB, Wang H, Pruitt LC, Zhang Q et al..  2009.  Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.. PloS one. 4(11):e7916. Abstract
Pitteri SJ, Hanash SM, Aragaki A, Amon LM, Chen L, Busald Buson T, Paczesny S, Katayama H, Wang H, Johnson MM et al..  2009.  Postmenopausal estrogen and progestin effects on the serum proteome.. Genome medicine. 1(12):121. Abstract
Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda EA, Wang H, Zhang Q, Newcomb L, Krasnoselsky A, Paczesny S, Choi G et al..  2008.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.. Journal of proteome research. 7(4):1481-9. Abstract
Pitteri SJ, Amon LM, Busald Buson T, Zhang Y, Johnson MM, Chin A, Kennedy J, Wong C-H, Zhang Q, Wang H et al..  2010.  Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.. Cancer research. 70(21):8598-606. Abstract
Paczesny S, Braun TM, Levine JE, Hogan J, Crawford J, Coffing B, Olsen S, Choi SW, Wang H, Faca V et al..  2010.  Elafin is a biomarker of graft-versus-host disease of the skin.. Science translational medicine. 2(13):13ra2. Abstract
M
May D, Liu Y, Law W, Fitzgibbon M, Wang H, Hanash S, McIntosh M.  2008.  Peptide sequence confidence in accurate mass and time analysis and its use in complex proteomics experiments.. Journal of proteome research. 7(12):5148-56. Abstract
L
Ladd J, Busald Buson T, Johnson M, Zhang Q, Pitteri SJ, Wang H, Brenner DE, Lampe PD, Kucherlapati RS, Feng Z et al..  2012.  Increased plasma levels of the APC-interacting protein MAPRE1, LRG1 and IGFBP2 preceding a diagnosis of colorectal cancer in women.. Cancer prevention research (Philadelphia, Pa.). 5(4):655-664. Abstract
K
Kelly-Spratt KS, Pitteri SJ, Gurley KE, Liggitt D, Chin A, Kennedy J, Wong C-H, Zhang Q, Busald Buson T, Wang H et al..  2011.  Plasma proteome profiles associated with inflammation, angiogenesis, and cancer.. PloS one. 6(5):e19721. Abstract
Katayama H, Paczesny S, Prentice RL, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J et al..  2009.  Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings.. Genome medicine. 1(4):47. Abstract
Katayama H, Boldt C, Ladd JJ, Johnson MM, Chao T, Capello M, Suo J, Mao J, Manson JE, Prentice R et al..  2015.  An autoimmune response signature associated with the development of triple negative breast cancer reflects disease pathogenesis.. Cancer research. 75(16):3246-54. Abstract
H
Howard BV, Metzger JS, Koller KR, Jolly SE, Asay ED, Wang H, Wolfe AW, Hopkins SE, Kaufmann C, Raymer TW et al..  2014.  All-Cause, Cardiovascular, and Cancer Mortality in Western Alaska Native People: Western Alaska Tribal Collaborative for Health (WATCH).. American journal of public health. Abstract